ROLE OF HUMAN CYTOCHROME P450 (CYP) IN THE METABOLIC ACTIVATION OF NITROSAMINE DERIVATIVES: APPLICATION OF GENETICALLY ENGINEERED SALMONELLA EXPRESSING HUMAN CYP

REFERENCES

• Parkinson A. Biotransformation of Xenobiotics. Casarett and Doull's Toxicology: The Basic Science of Poisons, C.D. Klassen. McGraw-Hill, New York 1996; 113–186
   Google Scholar
• Pilot H.C., III, Dragan Y.P. Chemical Carcinogenesis. Casarett and Doull's Toxicology: The Basic Science of Poisons, C.D. Klassen. McGraw-Hill, New York 1996; 201–267
   Google Scholar
• Dragan Y.P. Somatic Mutation Theory of Carcinogenesis. Comprehensive Toxicology: Chemical Carcinogens and Anticarcinogens, G.T. Bowden, S.M. Fischer. Elsevier Sciences, Oxford 1997; Vol. 12: 31–53
   Google Scholar
• Nelson D.R., Koymans L., Kamataki T., Stegeman J.J., Feyereisen R., Waxman D.J., Waterman M.R., Gotoh O., Coon M.J., Estabrook R.W., Gunsalus I.C., Nebert D.W. P450 Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers and Nomenclature. Pharmacogenetics 1996; 6(1)1–42
   PubMedGoogle Scholar
• Guengerich F.P., Shimada T. Oxidation of Toxic and Carcinogenic Chemicals by Human Cytochrome P-450 Enzymes. Chem. Res. Toxicol. 1991; 4(4)391–407
   PubMed Web of Science ®Google Scholar
• Vermeulen N.P.E. Role of Metabolism in Chemical Toxicity. Cytochromes P450: Metabolic and Toxicological Aspects, C. Ioannides. CRC Press, New York 1996; 29–53
   Google Scholar
• Kushida H., Fujita K., Suzuki A., Yamada M., Nohmi T., Kamataki T. Development of a Salmonella Tester Strain Sensitive to Promutagenic N-Nitrosamines: Expression of Recombinant CYP2A6 and Human NADPH–Cytochrome P450 Reductase in S. typhimurium YG7108. Mutat. Res. 2000; 471(1–2)135–143
   PubMed Web of Science ®Google Scholar
• Kushida H., Fujita K., Suzuki A., Yamada M., Endo T., Nohmi T., Kamataki T. Metabolic Activation of N-Alkylnitrosamines in Genetically Engineered Salmonella typhimurium Expressing CYP2E1 or CYP2A6 Together with Human NADPH–Cytochrome P450 Reductase. Carcinogenesis 2000; 21(6)1227–1232
   PubMed Web of Science ®Google Scholar
• Fujita, K.; Nakayama, K.; Yamazaki, Y.; Tsuruma, K.; Yamada, M.; Nohmi, T.; Kamataki, T. Construction of Salmonella typhimurium YG7108 Strains Each Co-expressing a Form of Human Cytochrome P450 with NADPH–Cytochrome P450 Reductase., (), –.
   Google Scholar
• Yamada M., Sedgwick B., Sofuni T., Nohmi T. Construction and Characterization of Mutants of Salmonella typhimurium Deficient in DNA Repair of O6-Methylguanine. J. Bacteriol. 1995; 177(6)1511–1519
   PubMed Web of Science ®Google Scholar
• Fujita K., Kamataki T. Predicting the Mutagenicity of Tobacco-Related N-Nitrosamines in Humans Using Eleven Strains of Salmonella typhimurium YG7108 Each Co-expressing a Form of Human Cytochrome P450 Along with NADPH–Cytochrome P450 Reductase. Environ. Mol. Mutagen. 2001; 38(4)339–346
   PubMed Web of Science ®Google Scholar
• Yokoi T., Kosaka Y., Chida M., Chiba K., Nakamura H., Ishizaki T., Kinoshita M., Sato K., Gonzalez F.J., Kamataki T. A New CYP2D6 Allele with a Nine Base Insertion in Exon 9 in a Japanese Population Associated with Poor Metabolizer Phenotype. Pharmacogenetics 1996; 6(5)395–401
   PubMedGoogle Scholar
• Nakamura K., Yokoi T., Inoue K., Shimada N., Ohashi N., Kume T., Kamataki T. CYP2D6 Is a Principal Cytochrome P450 Responsible for Metabolism of the Histamine H1 Antagonist Promethazine in Human Liver Microsomes. Pharmacogenetics 1996; 6(5)449–457
   PubMedGoogle Scholar
• Nunoya K., Yokoi T., Kimura K., Inoue K., Kodama T., Funayama M., Nagashima K., Funae Y., Green C., Kinoshita M., Kamataki T. A New Deleted Allele in Human Cytochrome P4502A6 (CYP2A6) Gene Found in Human Liver Subjects Showing Poor Metabolic Capacity to Coumarin and (+)-cis-3,5-Dimethyl-2-(3-Pyridyl) Thiazolidin-4-One Hydrochloride (SM-12502). Pharmacogenetics 1998; 8(3)239–249
   PubMedGoogle Scholar
• Nunoya K., Yokoi T., Kimura K., Kainuma T., Sato K., Kinoshita M., Kamataki T. CYP2A6 Gene Deletion Responsible for the In Vivo Polymorphic Metabolism of (+)-cis-3,5-Dimethyl-2-(3-Pyridyl) Thiazolidine-4-One Hydrochloride (SM-12502) in Humans. J. Pharmacol. Exp. Ther. 1999; 289(1)437–442
   PubMed Web of Science ®Google Scholar
• Chida M., Yokoi T., Nemoto N., Inaba M., Kinoshita M., Kamataki T. A New Variant CYP2D6 Allele (CYP2D6/C8) with a Single Insertion in Exon 5 in a Japanese Population Associated with a Poor Metabolizer Phenotype. Pharmacogenetics 1999; 9(3)287–293
   PubMedGoogle Scholar
• Chida M., Yokoi T., Kosaka Y., Chiba K., Nakamura H., Ishizaki T., Yokota J., Kinoshita M., Sato K., Inaba M., Aoki Y., Gonzalez F.J., Kamataki T. Genetic Polymorphism of CYP2D6 in Japanese Population. Pharmacogenetics 1999; 9(5)601–605
   PubMedGoogle Scholar
• Tateishi T., Chida M., Ariyoshi N., Mizorogi Y., Kamataki T., Kobayashi S. Analysis of the CYP2D6 Gene in Relation to Dextromethorphan O-Demethylation Capacity in a Japanese Population. Clin. Pharmacol. Ther. 1999; 65(5)570–575
   PubMed Web of Science ®Google Scholar
• Nunoya K., Yokoi T., Takahashi Y., Kimura K., Kinoshita M., Kamataki T. Homologous Unequal Cross-Over Within the Human CYP2A Gene Cluster as a Mechanism for the Deletion of Entire CYP2A6 Gene Associated with the Poor Metabolizer Phenotype. J. Biochem. 1999; 126(2)402–407
   PubMed Web of Science ®Google Scholar
• Miyamoto M., Umetsu Y., Dosaka-Akita H., Sawamura Y., Yokota J., Kunitoh K., Nemoto N., Sato K., Ariyoshi N., Kamataki T. CYP2A6 Gene Deletion Reduces Susceptibility to Lung Cancer. Biochem. Biophys. Res. Commun. 1999; 261(3)658–660
   PubMed Web of Science ®Google Scholar
• Iwata H., Fujita K., Kushida H., Suzuki A., Konno Y., Nakamura K., Fujino A., Kamataki T. High Catalytic Activity of Human Cytochrome P450 Co-expressed with Human NADPH–Cytochrome P450 Reductase in Escherichia coli. Biochem. Pharmacol. 1998; 55(8)1315–1325
   PubMed Web of Science ®Google Scholar
• Shimada T., Wunsch R.M., Hanna I.H., Sutter T.R., Guengerich F.P., Gillam E.M.J. Recombinant Human Cytochrome P450 1B1 Expression in Escherichia coli. Arch. Biochem. Biophys. 1998; 357(1)111–120
   PubMed Web of Science ®Google Scholar
• Gillam E.M.J., Guo Z., Ueng Y.F., Yamazaki H., Cock I., Reilly P.E.B., Hooper W.D., Guengerich F.P. Expression of Cytochrome P450 3A5 in Escherichia coli: Effects of 5′ Modification, Purification, Spectral Characterization, Reconstitution Conditions, and Catalytic Activities. Arch. Biochem. Biophys. 1995; 317(2)374–384
   PubMed Web of Science ®Google Scholar
• Bullas L.R., Ryu J. Salmonella typhimurium LT2 Strains Which Are r−m+ for All Three Chromosomally Located Systems of DNA Restriction and Modification. J. Bacteriol. 1983; 156(1)471–474
   PubMed Web of Science ®Google Scholar
• Shimada T., Yamazaki H., Mimura M., Inui Y., Guengerich F.P. Interindividual Variations in Human Liver Cytochrome P-450 Enzymes Involved in the Oxidation of Drugs, Carcinogens and Toxic Chemicals: Studies with Liver Microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 1994; 270(1)414–423
   PubMed Web of Science ®Google Scholar
• Peterson J., Ebel R.E., O'Keeffe D.H., Matsubara T., Estabrook R.W. Temperature Dependence of Cytochrome P-450 Reduction. J. Biol. Chem. 1976; 251(13)4010–4016
   PubMed Web of Science ®Google Scholar
• Taniguchi H., Imai Y., Iyanagi T., Sato R. Interaction Between NADPH–Cytochrome P-450 Reductase and Cytochrome P-450 in the Membrane of Phosphatidylcholine Vesicles. Biochem. Biophys. Acta 1979; 550(2)341–356
   PubMed Web of Science ®Google Scholar
• Pearce R., Greenway D., Parkinson A. Species Differences and Interindividual Variation in Liver Microsomal Cytochrome P450 2A Enzymes: Effects on Coumarin, Dicumarol, and Testosterone Oxidation. Arch. Biochem. Biophys. 1992; 298(1)211–225
   PubMed Web of Science ®Google Scholar
• Ono S., Hatanaka T., Hotta H., Satoh T., Gonzalez F.J., Tsutsui M. Specificity of Substrate and Inhibitor Probes for Cytochrome P450s: Evaluation of In Vitro Metabolism Using cDNA-Expressed Human P450s and Human Liver Microsomes. Xenobiotica 1996; 26(7)681–693
   PubMed Web of Science ®Google Scholar
• Araki A., Muramatsu M., Matsushima T. Comparison of Mutagenicities of N-Nitrosamines on Salmonella typhimurium TA100 and Escherichia coli WP2 UvrA/pKM101 Using Rat and Hamster Liver S9. Gann 1984; 75(1)8–16
   PubMedGoogle Scholar
• Suzuki A., Kushida H., Iwata H., Watanabe M., Nohmi T., Fujita K., Gonzalez F.J., Kamataki T. Establishment of a Salmonella Tester Strain Highly Sensitive to Mutagenic Heterocyclic Amines. Cancer Res. 1998; 58(9)1833–1838
   PubMed Web of Science ®Google Scholar